Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy - The Lancet Respiratory Medicine
Frontiers | Dissecting the Role of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis: Cause or Solution
JCI Insight - Role of endothelial cells in pulmonary fibrosis via SREBP2 activation
Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis | Nature Communications
Administration of aloperine attenuated lung fibrosis after BLM... | Download Scientific Diagram
Club cell-specific role of programmed cell death 5 in pulmonary fibrosis | Nature Communications
MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics - ScienceDirect
Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation
Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine | ACS Pharmacology & Translational Science
The potential indicators for pulmonary fibrosis in survivors of severe COVID-19 - Journal of Infection
Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung | Scientific Reports
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis | SpringerLink
Fibroblasts and their responses to chronic injury in pulmonary fibrosis - ScienceDirect
Frontiers | The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
The pathogenesis of pulmonary fibrosis: a moving target | European Respiratory Society
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis | Cell Death & Disease
Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators - The American Journal of Pathology
Unifying mechanism for different fibrotic diseases | PNAS
Frontiers | Quantification of Lung Fibrosis in IPF-Like Mouse Model and Pharmacological Response to Treatment by Micro-Computed Tomography
JCI - Fra-2–expressing macrophages promote lung fibrosis
Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin - ScienceDirect
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis | EMBO Molecular Medicine
Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes | Fibrogenesis & Tissue Repair | Full Text
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into | JIR
IJMS | Free Full-Text | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs | HTML
Molecular biomarkers in idiopathic pulmonary fibrosis | American Journal of Physiology-Lung Cellular and Molecular Physiology
IJMS | Free Full-Text | Idiopathic Pulmonary Fibrosis: Pathogenesis and the Emerging Role of Long Non-Coding RNAs | HTML
Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis | The Journal of Immunology
Interstitial Lung Disease | ARUP Laboratories
![Differential Lysotracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis[v1] | Preprints](https://www.preprints.org/img/dyn_abstract_figures/2021/11/1272817178e65d48c7849464c391563d/preprints-52023-graphical.v1(1).jpg "Differential Lysotracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis[v1] | Preprints")